Paper37243271
Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC.
Ding S and 16 others. Viruses, 2023. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Piperidine CD4-Mimetic Compounds Expose Vulnerable Env Epitopes Sensitizing HIV-1-Infected Cells to ADCC. Papers, record 37243271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37243271
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| HIV-1 | Major topic |
| HIV Seropositivity | Major topic |
| HIV Infections | Major topic |
| Humans | |
| Epitopes | |
| CD4-Positive T-Lymphocytes | |
| CD4 Antigens | |
| Antibody-Dependent Cell Cytotoxicity | |
| HIV Envelope Protein gp120 | |
| HIV Antibodies |
Source PubMed
Grants8
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI148379 | NIAID NIH HHS | United States | R01AI148379 | PubMed and NIH | NIH RePORTER |
| P01 AI150471 | NIAID NIH HHS | United States | P01AI150471 | PubMed | NIH RePORTER |
| R01 AI129769 | NIAID NIH HHS | United States | R01AI129769 | PubMed and NIH | NIH RePORTER |
| P01 GM056550 | NIGMS NIH HHS | United States | P01GM056550 | PubMed and NIH | NIH RePORTER |
| UM1 AI164562 | NIAID NIH HHS | United States | UM1AI164562 | PubMed and NIH | NIH RePORTER |
| P01 AI162242 | NIAID NIH HHS | United States | P01AI162242 | PubMed | NIH RePORTER |
| R01AI150322 | NIH | NIH RePORTER | |||
| R01AI174908 | NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Update of | 36993184 |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15299374 | The CCP4 suite: programs for protein crystallography. | Acta Crystallogr D Biol Crystallogr | 1994 | https://conductscience.org/library/papers/15299374 | PubMed |
| 2 | 22628654 | Linking crystallographic model and data quality. | Science | 2012 | https://conductscience.org/library/papers/22628654 | PubMed |
| 3 | 27754618 | Processing of X-ray diffraction data collected in oscillation mode. | Methods Enzymol | 1997 | https://conductscience.org/library/papers/27754618 | PubMed |
| 4 | 19939925 | Tiered categorization of a diverse panel of HIV-1 Env pseudoviruses for assessment of neutralizing antibodies. | J Virol | 2010 | https://conductscience.org/library/papers/19939925 | PubMed |
| 5 | 26637462 | A Highly Conserved Residue of the HIV-1 gp120 Inner Domain Is Important for Antibody-Dependent Cellular Cytotoxicity Responses Mediated by Anti-cluster A Antibodies. | J Virol | 2016 | https://conductscience.org/library/papers/26637462 | PubMed |
| 6 | 18488318 | Free R value: cross-validation in crystallography. | Methods Enzymol | 1997 | https://conductscience.org/library/papers/18488318 | PubMed |
| 7 | 32184972 | Optimization of Small Molecules That Sensitize HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity. | ACS Med Chem Lett | 2020 | https://conductscience.org/library/papers/32184972 | PubMed |
| 8 | 29559570 | Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses. | mBio | 2018 | https://conductscience.org/library/papers/29559570 | PubMed |
| 9 | 24696475 | CD4-mimetic small molecules sensitize human immunodeficiency virus to vaccine-elicited antibodies. | J Virol | 2014 | https://conductscience.org/library/papers/24696475 | PubMed |
| 10 | 2986290 | Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. | Science | 1985 | https://conductscience.org/library/papers/2986290 | PubMed |
| 11 | 32457241 | The HIV-1 Env gp120 Inner Domain Shapes the Phe43 Cavity and the CD4 Binding Site. | mBio | 2020 | https://conductscience.org/library/papers/32457241 | PubMed |
| 12 | 29350181 | A single, continuous metric to define tiered serum neutralization potency against HIV. | Elife | 2018 | https://conductscience.org/library/papers/29350181 | PubMed |
| 13 | 27846736 | Short Communication: Small-Molecule CD4 Mimetics Sensitize HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Nonhuman Primates. | AIDS Res Hum Retroviruses | 2017 | https://conductscience.org/library/papers/27846736 | PubMed |
| 14 | 16051803 | Recommendations for the design and use of standard virus panels to assess neutralizing antibody responses elicited by candidate human immunodeficiency virus type 1 vaccines. | J Virol | 2005 | https://conductscience.org/library/papers/16051803 | PubMed |
| 15 | 31554684 | A New Family of Small-Molecule CD4-Mimetic Compounds Contacts Highly Conserved Aspartic Acid 368 of HIV-1 gp120 and Mediates Antibody-Dependent Cellular Cytotoxicity. | J Virol | 2019 | https://conductscience.org/library/papers/31554684 | PubMed |
| 16 | 9632381 | The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. | Science | 1998 | https://conductscience.org/library/papers/9632381 | PubMed |
| 17 | 30974085 | An Asymmetric Opening of HIV-1 Envelope Mediates Antibody-Dependent Cellular Cytotoxicity. | Cell Host Microbe | 2019 | https://conductscience.org/library/papers/30974085 | PubMed |
| 18 | 29915222 | A CD4-mimetic compound enhances vaccine efficacy against stringent immunodeficiency virus challenge. | Nat Commun | 2018 | https://conductscience.org/library/papers/29915222 | PubMed |
| 19 | 25339767 | The HIV-1 gp120 CD4-bound conformation is preferentially targeted by antibody-dependent cellular cytotoxicity-mediating antibodies in sera from HIV-1-infected individuals. | J Virol | 2015 | https://conductscience.org/library/papers/25339767 | PubMed |
| 20 | 19000821 | Small-molecule CD4 mimics interact with a highly conserved pocket on HIV-1 gp120. | Structure | 2008 | https://conductscience.org/library/papers/19000821 | PubMed |
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41583464 | Viral glycoprotein-mediated entry and antibody-mediated immunity in HIV-1 and SARS-CoV-2 infection. | Front Immunol | 2025 | https://conductscience.org/library/papers/41583464 | PubMed |
| 41326374 | The asymmetric opening of HIV-1 Env by a potent CD4 mimetic enables anti-coreceptor binding site antibodies to mediate ADCC. | Nat Commun | 2025 | https://conductscience.org/library/papers/41326374 | PubMed |
| 39563795 | Optimization of a Piperidine CD4-Mimetic Scaffold Sensitizing HIV-1 Infected Cells to Antibody-Dependent Cellular Cytotoxicity. | ACS Med Chem Lett | 2024 | https://conductscience.org/library/papers/39563795 | PubMed |
| 39248460 | The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity. | J Virol | 2024 | https://conductscience.org/library/papers/39248460 | PubMed |
| 38895270 | The combination of three CD4-induced antibodies targeting highly conserved Env regions with a small CD4-mimetic achieves potent ADCC activity. | bioRxiv | 2024 | https://conductscience.org/library/papers/38895270 | PubMed |
| 37888980 | V3 tip determinants of susceptibility to inhibition by CD4-mimetic compounds in natural clade A human immunodeficiency virus (HIV-1) envelope glycoproteins. | J Virol | 2023 | https://conductscience.org/library/papers/37888980 | PubMed |
| 37872202 | Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir. | Nat Commun | 2023 | https://conductscience.org/library/papers/37872202 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AD8 | 353128 | PubTator's text mining | https://conductscience.org/library/genes/353128 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CYTH1 | 9267 | PubTator's text mining | https://conductscience.org/library/genes/9267 | NCBI Gene |
| ITIH4 | 3700 | PubTator's text mining | https://conductscience.org/library/genes/3700 | NCBI Gene |
| NRSN1 | 140767 | PubTator's text mining | https://conductscience.org/library/genes/140767 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37243271
GET https://conductscience.org/api/papers/v1/37243271/references?page=2